Palliative treatment of malignant ascites #177

Journal of Palliative Medicine

Volumn 13, Issue 8, 2010, Pages 1028-1029

  Leblanc, Karen ^a   Arnold, Robert M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT;

ASCITES; BLOOD VESSEL SHUNT; HUMAN; PALLIATIVE THERAPY; PARACENTESIS; PORTAL HYPERTENSION; SHORT SURVEY; SURGICAL TECHNIQUE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ASCITES; DIURETICS; DRAINAGE; HUMANS; NEOPLASMS; PALLIATIVE CARE; PARACENTESIS; PERITONEOVENOUS SHUNT; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 77955887305     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2010.9799     Document Type: Short Survey

References (9)

1. Thomas J, von Gunten CF: Diagnosis and management of ascites. In Berger AM, Von Roenn J, Schuster J, eds. Principles and Practice of Palliative Care and Supportive Oncology, 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2006.
2. Adam RA, Adam YG: Malignant ascites: Past, present, and future. J Am Coll Surg 2004;198:999-1011.
3. Spratt JS, Edwards M, Kubota T, et al: Peritoneal carcinomatosis: Anatomy, physiology, diagnosis, management. Curr Probl Cancer 1986;10:553-584.
4. Becker G, Galandi D, Blum HE: Malignant ascites: Systematic review and guideline for treatment. Eur J Cancer 2006;42: 589-597.
5. Aslam N, Marino CR: Malignant ascites: New concepts in pathophysiology, diagnosis, and management. Arch Intern Med 2001;161:2733-2737.
6. Smith EM, Jayson GC: The current and future management of malignant ascites. Clin Oncol 2003;15:59-72.
7. Pockros PJ, Esrason KT, Nguyen C, Duque J, Woods S: Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics. Gastroenterology 1992;103: 1302-1306.
8. Abeloff M, Armitage J, Niederhuber J, Kastan M, McKenna WG, eds: Clinical Oncology, 3rd ed. New York: Churchill Livingstone; 2004: 1199-1205.
9. Covey AM: Management of malignant pleural effusions and ascites. J Support Oncol 2005;3:169-173.